SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934
Filed by the Registrant [ x ]
Filed by a Party other than the Registrant [ ]
Check the appropriate box:
[ ] Preliminary Proxy Statement
[ ] Confidential, for Use of the Commission Only (as permitted by Rule
14a-6(e)(2))
[ x ] Definitive Proxy Statement
[ ] Definitive Additional Materials
[ ] Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12
CONMED CORPORATION
----------------------------------------------
(Name of Registrant as Specified in Its Charter)
----------------------------------------------------------------------
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
[ x ] $125 per Exchange Act Rules 0-11(c)(1)(ii), 14a-6(i)(1), 14a-6(i)(2) or
Item 22(a)(2) of Schedule 14A.
[ ] $500 per each party to the controversy pursuant to Exchange Act
Rule 14a-6(i)(3).
[ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
1) Title of each class of securities to which transaction applies:
_______________________________________________________________________
2) Aggregate number of securities to which transaction applies:
_______________________________________________________________________
3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the
filing fee is calculated and state how it was determined):
_______________________________________________________________________
4) Proposed maximum aggregate value of transaction:
_______________________________________________________________________
5) Total fee paid:
_______________________________________________________________________
[ ] Fee paid previously with preliminary materials.
[ ] Check box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting fee was
paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.
1) Amount Previously Paid:
_______________________________________________________________________
2) Form, Schedule or Registration Statement No.:
_______________________________________________________________________
3) Filing Party:
_______________________________________________________________________
4) Date Filed:
_______________________________________________________________________
CONMED CORPORATION
310 Broad Street
Utica, New York 13501
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
NOTICE IS HEREBY GIVEN that the Annual Meeting of Shareholders of
CONMED Corporation (the "Company") will be held at the Radisson Hotel-Utica
Centre, 200 Genesee Street, Utica, New York on Tuesday, May 23, 1995, at 3:30
P.M. (New York Time), for the following purposes:
(1) To elect five Directors to serve on the Company's Board of
Directors;
(2) To appoint independent accountants for the Company for fiscal year
1995;
(3) To approve the adoption of the Company's Stock Option Plan for
Non-Employee Directors; and
(4) To transact such other business as may properly be brought before
the meeting or any adjournment thereof.
The shareholders of record at the close of business on April 4, 1995
are entitled to notice of and to vote at this Annual Meeting or any adjournment
thereof.
Even if you plan to attend the meeting in person, we request that you
mark, date, sign and return your proxy in the enclosed self-addressed envelope
as soon as possible so that your shares may be certain of being represented and
voted at the meeting. Any proxy given by a shareholder may be revoked by that
shareholder at any time prior to the voting of the proxy.
By Order of the Board of Directors,
Thomas M. Acey
Secretary
April 19, 1995
CONMED CORPORATION
310 Broad Street
Utica, New York 13501
PROXY STATEMENT
ANNUAL MEETING OF SHAREHOLDERS
May 23, 1995
The enclosed proxy is solicited by and on behalf of the Board of
Directors of CONMED Corporation (the "Company") for use at the Annual Meeting of
Shareholders to be held Tuesday, May 23, 1995, at 3:30 P.M. (New York Time), at
the Radisson Hotel-Utica Centre, 200 Genesee Street, Utica, New York and any
adjournment thereof. The matters to be considered and acted upon at such meeting
are described in the foregoing notice of the meeting and this proxy statement.
This proxy statement and the related form of proxy are being mailed on or about
April 19, 1995 to all shareholders of record on April 4, 1995. Shares of the
Company's Common Stock, par value $.01 per share (the "Common Stock"),
represented in person or by proxy will be voted as hereinafter described or as
otherwise specified by the shareholder. Any proxy given by a shareholder may be
revoked by the shareholder at any time prior to the voting of the proxy by
delivering a written notice to the Secretary of the Company, by executing and
delivering a later-dated proxy or by attending the meeting and voting in person.
The persons named as proxies are Eugene R. Corasanti and Robert E.
Remmell, each of whom is presently a director and an officer of the Company. The
cost of preparing, assembling and mailing the proxy, this proxy statement, and
other material enclosed, and all clerical and other expenses of solicitations
will be borne by the Company. In addition to the solicitation of proxies by use
of the mails, directors, officers and employees of the Company and its
subsidiaries may solicit proxies by telephone, telegram or personal interview.
The Company also will request brokerage houses and other custodians, nominees
and fiduciaries to forward soliciting material to the beneficial owners of
Common Stock held of record by such parties and will reimburse such parties for
their expenses in forwarding soliciting material.
VOTING RIGHTS
The holders of record of the 7,127,254 shares of Common Stock
outstanding on April 4, 1995 will be entitled to one vote for each share held on
all matters coming before the meeting. The holders of a record of a majority of
the outstanding shares of Common Stock present in person or by proxy will
constitute a quorum for the transaction of business at the meeting.
ANNUAL REPORT
The annual report for the fiscal year ended December 30, 1994,
including financial statements, is being furnished herewith to shareholders of
record on April 4, 1995. The annual report does not constitute a part of the
proxy soliciting material.
SECURITY OWNERSHIP OF CERTAIN
BENEFICIAL OWNERS AND MANAGEMENT
The following table sets forth certain information with respect to the
beneficial ownership of the Company's Common Stock as of April 4, 1995, by each
shareholder known by the Company to be the beneficial owner of more than 5% of
its outstanding Common Stock, by each director, by each of the Named Executive
Officers (as defined below) and by all directors and executive officers as a
group.
Amount and Nature
of Beneficial Percent
Name of Beneficial Owner* Ownership of Class
- ------------------------- ------------------ --------
William W. Abraham(1) ........................... 141,450 1.97
Harry Cone(2) ................................... 171,000 2.40
Eugene R. Corasanti(3) .......................... 411,600 5.60
Joseph J. Corasanti(4) .......................... 32,800 (5)
Bruce F. Daniels(6) ............................. 2,250 (5)
Joseph B. Gross (7).............................. 18,675 (5)
Jeffrey H. Palmer (7)............................ 27,300 (5)
Robert E. Remmell ............................... 3,000 (5)
Robert D. Shallish, Jr. (8)...................... 28,050 (5)
Directors and officers as a group ............... 910,705 11.99
(11 persons) (2)(3)(6)(9)
Zimmer, Inc. .................................... [461,909] 6.09
P.O. Box 708
Warsaw, Indiana 46850(10)
Fenimore Asset Management, Inc. ................. 1,111,124 15.59
118 North Grand Street
P.O. Box 310
Cobleskill, New York 12043(11)
FMR Corp. ....................................... 490,950 6.89
82 Devonshire Street
Boston, Massachusetts 02109(12)
- ----------------
* Unless otherwise set forth above, the address of each of the above listed
shareholders is c/o CONMED Corporation, 310 Broad Street, Utica, New York
13501.
(1) Includes 55,500 shares subject to options, exercisable within 60 days.
(2) Includes an aggregate of 96,000 shares owned beneficially by the wife of
Harry Cone. Mr. Cone disclaims beneficial ownership of these shares.
(3) Includes 225,000 shares subject to options, exercisable within 60 days.
Includes an aggregate of 29,850 shares owned beneficially by the wife of
Eugene R. Corasanti. Eugene R. Corasanti disclaims beneficial ownership of
these shares.
(4) Includes 3,600 shares subject to options, exercisable within 60 days.
Joseph J. Corasanti is the son of Eugene R. Corasanti.
(5) Less than 1%.
(6) Consists of an aggregate of 2,250 shares owned beneficially by the wife of
Bruce F. Daniels. Mr. Daniels disclaims beneficial ownership of these
shares.
(7) Consists of shares subject to options, exercisable within 60 days.
(8) Includes 25,100 shares subject to options, exercisable within 60 days.
(9) Includes 420,155 shares subject to options, exercisable within 60 days,
held by William W. Abraham, Eugene R. Corasanti, Joseph J. Corasanti,
Joseph B. Gross, Jeffrey H. Palmer, Robert D. Shallish, Jr., Frank R.
Williams and Thomas M. Acey, executive officers of the Company. Such
420,155 shares are equal to approximately 5.50% of the Common Stock
outstanding. As of April 4, 1995, the Company's directors and officers as a
group (11 persons) owned 362,450 shares, which is approximately 5.08% of
the Common Stock outstanding.
(10) Represents warrant to purchase shares of Common Stock, exercisable within
60 days.
(11) A Schedule 13G filed with the Securities and Exchange Commission (the
"SEC") by Fenimore Asset Management, Inc. on February 2, 1995, indicates
that Fenimore Asset Management, Inc. beneficially owns 1,111,124 shares of
Common Stock.
(12) A Schedule 13G filed with the SEC by FMR Corp. on February 13, 1995
indicates that FMR Corp. beneficially owns 490,950 shares of Common Stock.
On April 4, 1995 there were 2,415 shareholders of record of the
Company's Common Stock.
PROPOSAL ONE: ELECTION OF DIRECTORS
At the meeting, five directors are to be elected to serve on the
Company's Board of Directors. The shares represented by proxies will be voted as
specified by the shareholder. If the shareholder does not specify his choice,
the shares will be voted in favor of the election of the nominees listed on the
proxy card, except that in the event any nominee should not continue to be
available for election, such proxies will be voted for the election of such
other persons as the Board of Directors may recommend. The Company does not
presently contemplate that any of the nominees will become unavailable for
election for any reason. The director nominees who receive the greatest number
of votes at the meeting will be elected to the Board of Directors of the
Company. Votes against a candidate have no legal effect.
Shareholders are not entitled to cumulative voting rights.
The Board of Directors recommends a vote FOR this proposal.
Pursuant to the Company's By-laws, the Board of Directors consists of
five directors. Directors hold office for terms expiring at the next annual
meeting of shareholders and until their successors are duly elected and
qualified. Each of the nominees proposed for election at the Annual Meeting is
presently a member of the Board of Directors and has been elected by the
shareholders.
The following table sets forth certain information regarding the
members of and nominees for the Board of Directors:
NOMINEES FOR ELECTION AT THE 1995 ANNUAL MEETING
Served As
Director Principal Occupation or
Name Age Since Position with the Company
- ---- --- --------- -------------------------
Harry Cone 74 1981 Certified Public Accountant, retired
Robert E. Remmell 64 1983 Member of Steates Remmell Steates & Dziekan (Attorneys)
and Assistant Secretary of the Company
Eugene R. Corasanti 64 1970 Chairman and President of the Company
Bruce F. Daniels 60 1992 Controller, Construction Division, Chicago Pneumatic Tool
Company
Joseph J. Corasanti 31 1994 Vice President of Legal Affairs and General Counsel of
the Company
DIRECTORS AND EXECUTIVE OFFICERS
Eugene R. Corasanti has served as Chairman, President and a Director of
the Company since its incorporation in 1970. Prior to that time he was an
independent public accountant. Mr. Corasanti holds a B.B.A. degree in Accounting
from Niagara University. Mr. Corasanti is also Chairman of the Board of
Directors of the Company. Eugene R. Corasanti's son, Joseph J. Corasanti, is a
Director and General Counsel of the Company.
William W. Abraham (age 63) joined the Company in May 1977 as General
Manager. He has served as the Company's Vice President-Manufacturing and
Engineering since June 1983. In November 1989 he was named Executive Vice
President and in March 1993, he was named Senior Vice President of the Company.
Mr. Abraham holds a B.S. degree in Industrial Management from Utica College.
Joseph J. Corasanti has served as Director and Vice President of Legal
Affairs of the Company since 1994 and as General Counsel of the Company since
March 1993. Prior to that time he was an Associate Attorney with the law firm of
Morgan, Wenzel & McNicholas, Los Angeles, California from 1990 to March 1993 and
a law school student at Whittier College School of Law from 1986 to 1989. Mr.
Corasanti holds a B.A. degree in Political Science from Hobart College and a
J.D. degree from Whittier College School of Law. Joseph J. Corasanti is the son
of Eugene R. Corasanti, Chairman, President and Chief Executive Officer of the
Company.
Joseph B. Gross (age 36) joined the Company as Manager of Manufacturing
Engineering in April 1988 and became Vice President-Operations in May 1992.
Prior to his employment with the Company, Mr. Gross was employed at Oneida Ltd.
Silversmiths. Mr. Gross holds a B.S. degree from the State University of New
York-College of Technology and a Master's degree in Business Administration from
Rensselaer Polytechnic Institute.
Jeffrey H. Palmer (age 51) joined the Company as National Sales Manager
in October 1988 and became Vice President-Sales in September 1989. Prior to his
employment with the Company, Mr. Palmer served as Director of Sales for the
Medical Products Division of AMSCO International for ten years.
Mr. Palmer holds a B.A. degree from Eastern Michigan University.
Robert D. Shallish, Jr. (age 46) joined the Company as Vice
President-Finance in December 1989. Prior to this he was employed as Controller
of Genigraphics Corporation in Syracuse, New York since 1984. He was employed by
Price Waterhouse as a certified public accountant and senior manager from 1972
through 1984. Mr. Shallish graduated with a B.A. degree in Economics from
Hamilton College and holds a Master's degree in Accounting from Syracuse
University.
Frank R. Williams (age 46) joined the Company in 1974 as Sales Manager
and Director of Marketing and became Vice President-Marketing and Sales in June
1983. In September 1989 he became Vice President-Business Development. Mr.
Williams graduated with a B.A. degree from Hartwick College in 1970 as a biology
major and did his graduate study in Human Anatomy at the University of Rochester
College of Medicine.
Thomas M. Acey (age 48) has been employed by the Company since August
1980 and has served as the Company's Treasurer since August 1988 and as the
Company's Secretary since January 1993. Mr. Acey holds a B.S. degree in Public
Accounting from Utica College and prior to joining the Company was employed by
the certified public accounting firm of Tartaglia & Benzo in Utica, New York.
Harry Cone has served as a Director of the Company since May 1981. Mr.
Cone is a certified public accountant and was a partner in the firm of Sugarman
& Cone (and its predecessor), Utica, New York, from 1958 until 1986 when he
became semi-retired.
Robert E. Remmell has served as a Director and Assistant Secretary of
the Company since June 1983. Mr. Remmell has been a partner since January 1961
of Steates Remmell Steates & Dziekan, New Hartford, New York, the Company's
corporate counsel. The Company paid approximately $14,000 to Steates Remmell
Steates & Dziekan for services rendered during fiscal year 1994.
Bruce F. Daniels has served as a Director of the Company since August
1992. Since 1993 Mr. Daniels has been the Controller of the Construction
Division of Chicago Pneumatic Tool Company, where he has been employed since
1974. From 1991 until 1993, he was the Controller of the International Division
of Chicago Pneumatic Tool Company and from 1981 until 1991, he was the
Controller of the Tool Division of Chicago Pneumatic Tool Company. Mr. Daniels
holds a B.S. degree in Business from Utica College.
The Company's Directors are elected at each annual meeting of
shareholders and serve until the next annual meeting and until their successors
are duly elected and qualified. Eugene R. Corasanti's employment is subject to
an employment agreement which expires December 31, 1996. The Company's other
officers are appointed by the Board of Directors and hold office at the will of
the Board of Directors.
MEETINGS OF THE BOARD OF DIRECTORS AND COMMITTEES
The Company has an Audit Committee presently consisting of Messrs.
Cone, Daniels and Remmell. The Audit Committee is charged with evaluating
accounting and control procedures and practices of the Company and reporting on
such to the Board of Directors. The Audit Committee also serves as direct
liaison with the Company's independent public accountants and recommends the
engagement or discharge of such auditors. The Audit Committee met one time
during fiscal year 1994.
The Company has a Stock Option Committee presently consisting of
Messrs. Cone, Daniels and Remmell. The Stock Option Committee administers the
Company's employee stock option plan and has authority to grant options to
officers and key employees, as designated by the Stock Option Committee, and to
determine the terms of such options in accordance with such plan. The Stock
Option Committee voted by unanimous written consent on resolutions three times
during fiscal year 1994.
The full Board of Directors met seven times during fiscal year 1994.
Each incumbent director attended or acted upon at least 75% of the total fiscal
year 1994 board meetings or unanimous consents and committee meetings or
unanimous consents held or acted upon during periods that he was a member of the
Board or such committees.
Each Director was paid $750 for the first meeting of 1994 and $1,000
for each of five of the remaining six meetings of the full Board of Directors
attended. If the Company's Stock Option Plan for Non-Employee Directors is
approved at the 1995 Annual Meeting, each non-employee director (Messrs. Cone,
Daniels and Remmell in 1995) who is elected, reelected or continuing as a
director will receive 1,000 options with an option price equal to the fair
market value of the Company's Common Stock on the business day following each
annual meeting of the shareholders, commencing with the annual meeting in 1995.
See "Proposal Three: Adoption of Stock Option Plan for Non-Employee Directors."
COMPENSATION OF EXECUTIVE OFFICERS
The following information relates to all plan and non-plan compensation
awarded to or earned by (i) Eugene R. Corasanti, the Chairman and President of
the Company (the "CEO"), and (ii) William W. Abraham, Jeffrey H. Palmer, Robert
D. Shallish, Jr. and Joseph B. Gross, the Company's four most highly compensated
executive officers, other than the CEO, who were serving as executive officers
of the Company at December 30, 1994 (the CEO and such officers, the "Named
Executive Officers").
The following information does not reflect any compensation awarded to
or earned by the Named Executive Officers subsequent to December 30, 1994,
except as may otherwise be indicated. Any compensation awarded to, earned by or
paid to the Named Executive Officers during fiscal year 1995 will be reported in
the proxy statement for the Company's 1996 Annual Meeting of Shareholders,
unless such compensation has been previously reported.
Summary Compensation Table
The following table sets forth for the Named Executive Officers for
each of the last three years: (i) the name and principal position of the
executive officer (column (a)); (ii) the year covered (column (b)); (iii) annual
compensation (columns (c), (d) and (e)), including: (A) base salary earned
during the year covered (column (c)); (B) bonus earned during the year covered
(column (d)); and (C) other annual compensation not properly categorized as
salary or bonus (column (e)); (iv) long-term compensation, including the sum of
the number of stock options granted (column (f)); and (v) all other compensation
for the covered year that the Company believes could not be properly reported in
any other column of the table (column (g)).
Summary Compensation Table
Long-Term
Compensation
Annual Compensation Awards
--------------------------------------- ------------
(a) (b) (c) (d) (e) (f) (g)
Other Annual All Other
Name and Principal Fiscal Salary Bonus Compensation Options Compensation
Position Year ($) ($)(1) ($) (#) ($)
- --------------------- ------ ------ ------ ------------ ------- ------------
Eugene R. Corasanti, 1994 $203,891 $100,000 $129,000(2) 75,000(3) -
Chairman of the Board 1993 203,891 - 117,000(2) - -
of Directors and 1992 206,776 - 70,000(2) 75,000(3) -
President
William W. Abraham, 1994 128,300 65,000 - - -
Senior Vice President 1993 121,900 - - 7,500(3) -
1992 114,750 - - 30,000(3) -
Jeffrey H. Palmer, 1994 106,680 54,600 - - -
Vice President-Sales 1993 99,640 - - 4,500(3) -
1992 96,120 - - 37,500(3) -
Robert D. Shallish, Jr., 1994 106,050 54,600 - - -
Vice President-Finance 1993 98,050 - - 4,500(3) -
1992 97,200 - - 15,000(3) -
Joseph B. Gross, 1994 105,000 54,600 - - -
Vice President- 1993 81,800 - - 4,500(3) -
Operations 1992 72,450 - - 15,000(3) -
- ------------------
(1) Includes cash bonuses in year earned even if paid after the fiscal year end.
(2) Amounts represent deferred compensation and accrued interest for Mr.
Corasanti. See the discussion of Mr. Corasanti's employment agreement,
below.
(3) Adjusted to give effect to the Company's three-for-two stock split in the
form of a stock dividend paid on December 27, 1994.
Eugene R. Corasanti has a five-year employment agreement (the
"Employment Agreement") with the Company, extending through December 31, 1996.
The Employment Agreement, as amended, provides for Mr. Corasanti to serve as
president and chief executive officer of the Company for five years at an annual
salary, not less than $200,000, as determined by the Board of Directors. Mr.
Corasanti also receives deferred compensation of $70,000 per year with interest
at 10% per annum, payable in 120 equal monthly installments upon his retirement
or to his beneficiaries at death, and is entitled to participate in the
Company's employee stock option plan and pension and other employee benefit
plans and such bonus or other compensatory arrangements as may be determined by
the Board of Directors. In the event that the Board of Directors should fail to
reelect Mr. Corasanti as president and chief executive officer or should
terminate his employment for reasons other than just cause, Mr. Corasanti will
become entitled to receive the balance of his base annual salary, and shall
continue to receive deferred compensation and other employment benefits, for the
balance of the Employment Agreement's five-year term. In the event of Mr.
Corasanti's death or disability, Mr. Corasanti or his estate or beneficiaries
will be entitled to receive 100% of his base annual salary and other employment
benefits (other than deferred compensation) for the balance of the Employment
Agreement's term. If, during the term of Mr. Corasanti's employment under the
Employment Agreement and within two years after a Change in Control his
employment with the Company is terminated by the Company other than for Cause or
by him for Good Reason (as such capitalized terms are defined in the Employment
Agreement), Mr. Corasanti will be entitled to receive (a) a lump sum payment
equal to three times the sum of (i) his base salary on the date of such
termination or his base salary in effect immediately prior to the Change in
Control, whichever is higher, plus (ii) the average of the bonuses, deferred
compensation, and incentive compensation awarded to Mr. Corasanti during the
three years prior to such termination; (b) continued coverage under the benefit
plans in which he participates for a period of two years from the date of such
early termination; (c) a lump sum payment equal to the aggregate amount credited
to his deferred compensation account; and (d) awards for the calendar year of
such termination under incentive plans maintained by the Company as though any
performance or objective criteria used in determining such awards were
satisfied. The Board of Directors has determined for 1995 that Mr. Corasanti's
compensation shall be $250,000.
The Company pays premiums on individual disability insurance policies
for Eugene R. Corasanti and Mr. Abraham. The Company is also paying the premiums
on three split-dollar life insurance policies for Eugene R. Corasanti as
described under "Certain Relationships and Related Transactions." In 1994,
premiums on these policies paid by the Company aggregated approximately $57,000.
As described more fully under "Certain Relationships and Related Transactions,"
the Company entered into a directors and officers insurance policy covering the
period from January 31, 1995 through January 31, 1996, which covers all
directors and officers of the Company and its subsidiaries.
STOCK OPTION PLANS
The 1992 Plan
In April 1992, the shareholders approved the CONMED Corporation 1992
Stock Option Plan (the "1992 Plan"). Under the 1992 Plan, in the discretion of
the Stock Option Committee of the Board of Directors (the "Committee"), options
may be granted to officers and key employees of the Company and its subsidiaries
for the purchase of shares of Common Stock. The Committee presently consists of
Messrs. Cone, Daniels and Remmell.
Options may be granted which are (i) incentive stock options within the
meaning of Internal Revenue Code Section 422 or (ii) options other than
incentive stock options (i.e., non-qualified options). A total of 675,000 shares
of Common Stock (subject to adjustment for stock splits and other changes in the
Company's capital structure) are reserved against the exercise of options to be
granted under the 1992 Plan. Shares reserved under an option which for any
reason expires or is terminated, in whole or in part, shall again be available
for the purposes of the 1992 Plan.
The 1983 Plan
In June 1983, the shareholders of the Company approved an employee
stock option plan (the "1983 Plan"), which was subsequently amended by the
shareholders on June 30, 1987 and April 10, 1992. The 1983 Plan calls for the
grant of both "incentive stock options" intended to qualify for special tax
treatment under the Internal Revenue Code of 1986 and other stock options.
Pursuant to the 1983 Plan, officers and key employees of the Company are
eligible for grants of stock options at the fair market value of the Company's
Common Stock on the date of grant, exercisable commencing one year after grant.
The 1983 Plan is administered by the Committee.
The 1983 Plan is no longer in effect and no options may be granted
thereunder. The 1983 Plan provides that the total amount of Common Stock for
which options may be granted shall not exceed 675,000 shares, subject to certain
adjustments for changes affecting the Common Stock, such as a merger,
consolidation, reorganization, recapitalization or stock split.
Stock Option Plan for Non-Employee Directors
For a description of the Company's Stock Option Plan for Non-Employee
Directors, proposed for adoption at the 1995 Annual Meeting, see "Proposal
Three: Adoption of Stock Option Plan for Non-Employee Directors."
Option Grants Table
The following table sets forth, with respect to grants of stock options
made during fiscal year 1994 to each of the Named Executive Officers: (i) the
name of the executive officer (column (a)); (ii) the number of options granted
(column (b)); (iii) the percent the grant represents of the total options
granted to all employees during fiscal year 1994; (iv) the per share exercise
price of the options granted (column (d)); (v) the expiration date of the
options (column (e)); and (vi) the potential realizable value of each grant,
assuming the market price of the Common Stock appreciates in value from the date
of grant to the end of the option term at a rate of (A) 5% per annum (column
(f)) and (B) 10% per annum (column (g)).
Option Grants in Fiscal Year 1994
Potential Realizable
Value at Assumed Annual
Rates of Stock Price
Appreciation for
Individual Grants Option Term
------------------------------------------------------ -----------------------
(a) (b) (c) (d) (e) (f) (g)
% of Total
Options Options Granted Exercise or
Granted to Employees in Base Price Expiration
Name (#) Fiscal Year 1994 ($/Sh) Date 5% ($) 10% ($)
---- ------ ---------------- ----------- ---------- ------ -------
Eugene R. Corasanti 75,000 77.7% $15.67 11/25/04 $1,914,358 $3,048,296
William W. Abraham - - - - - -
Jeffrey H. Palmer - - - - - -
Robert D. Shallish, Jr. - - - - - -
Joseph B. Gross - - - - - -
Aggregated Option Exercises and Year-End Option Value Table
The following table sets forth, with respect to each exercise of stock
options during fiscal year 1994 by each of the Named Executive Officers and the
year-end value of unexercised options on an aggregated basis: (i) the name of
the executive officer (column (a)); (ii) the number of shares received upon
exercise, or, if no shares were received, the number of securities with respect
to which the options were exercised (column (b)); (iii) the aggregate dollar
value realized upon exercise (column (c)); (iv) the total number of unexercised
options held at December 30, 1994, separately identifying the exercisable and
unexercisable options (column (d)); and (v) the aggregate dollar value of
in-the-money, unexercised options held at December 30, 1994, separately
identifying the exercisable and unexercisable options (column (e)). The
Company's stock option plans do not provide for stock appreciation rights.
Aggregated Option Exercises in Fiscal Year 1994 and
December 30, 1994 Option Values
(a) (b) (c) (d) (e)
Value of Unexercised
Number of Unexercised In-the-Money Options
Options at 12/30/94 (#) at 12/30/94 ($)(1)
---------------------- ---------------------
Shares Value
Name Acquired Realized Exercisable/ Exercisable/
on Exercise (#) ($) Unexercisable Unexercisable
--------------- --- ------------- -------------
Eugene R. Corasanti -- -- 225,000/75,000 $1,794,000/$1,175,000
William W. Abraham -- -- 46,500/21,000 $463,005/$292,000
Jeffrey H. Palmer 2,000 $48,000 18,900/16,100 $262,803/$231,212
Robert D. Shallish, Jr. -- -- 21,900/12,600 $166,278/$175,212
Joseph B. Gross -- -- 14,775/14,475 $213,659/$209,581
- ----------------
(1) Assumes $19.88 per share fair market value on December 30, 1994.
Pension Plans
The Company maintains a broadly based defined benefit pension plan (the
"Pension Plan") for all CONMED employees. The Pension Plan entitles a
participant to a normal monthly retirement benefit equal to 1 1/2% of the
participant's average monthly earnings over the period of employment times years
of service. Eugene R. Corasanti's deferred compensation is not included in the
calculation of his retirement benefits. Benefits are fully vested after five
years of service, starting from date of hire. Benefits are paid on a monthly
basis over the participant's life commencing on retirement, with 120 monthly
payments certain.
The Pension Plan represents a "fresh start" as of January 1, 1989,
replacing the three pension plans formerly in place. The three former plans have
been merged into the Pension Plan, which is the former broadly based plan with
the benefit formula increased from 1/2% of pay to 1 1/2% of pay. Benefits
accrued by participants under the former plans became fully vested as of
December 31, 1988 and will be paid, when due, from this "fresh start" Pension
Plan. Messrs. Eugene R. Corasanti and Abraham had accrued benefits under the
former plans. At December 31, 1988, those benefits totalled $45,384 per year for
Mr. Eugene R. Corasanti and $20,820 per year for Mr. Abraham, which will be paid
from the Pension Plan in addition to the benefits to be received under the
Pension Plan. As of December 30, 1994, Messrs. Eugene R. Corasanti, Abraham,
Palmer, Shallish and Gross had six, six, five, four and six years of credited
service, respectively.
CONMED Defined Benefit Plan
Years of Service
---------------------------------------------------------------------------------
Average
Pay 15 20 25 30 35
--- -- -- -- -- --
$125,000 $28,125 $37,500 $46,875 $56,250 $65,625
$150,000 33,750 45,000 56,250 67,500 78,750
$175,000(1) 33,750 45,000 56,250 67,500 78,750
$200,000(1) 33,750 45,000 56,250 67,500 78,750
$225,000(1) 33,750 45,000 56,250 67,500 78,750
$250,000(1) 33,750 45,000 56,250 67,500 78,750
$300,000(1) 33,750 45,000 56,250 67,500 78,750
$400,000(1) 33,750 45,000 56,250 67,500 78,750
$450,000(1) 33,750 45,000 56,250 67,500 78,750
$500,000(1) 33,750 45,000 56,250 67,500 78,750
- ------------
(1) 1994 statutory limit for straight life annuity benefit is $150,000 for
average pay and $118,800 of benefit.
BOARD OF DIRECTORS REPORT ON EXECUTIVE COMPENSATION
The Company's Board of Directors establishes the compensation plans and
specific compensation levels for executive officers and administers the
Company's stock option plans through the Stock Option Committee of the Board of
Directors (the "Committee"). The Committee is composed of three independent,
non-employee directors who have no interlocking relationships as defined by the
SEC.
The Board of Directors believes that the compensation of Eugene R.
Corasanti, the Company's President and Chairman ("CEO"), should be heavily
influenced by company performance, long-term growth and strategic positioning.
Therefore, although there is necessarily some subjectivity in setting the CEO's
salary, major elements of the compensation package are directly tied to company
performance, long-term growth and strategic positioning. This philosophy is
reflected in Mr. Corasanti's current five-year employment contract, which
provides for a base annual salary of $200,000 and permits the Board of Directors
to determine a higher salary in their discretion. The Board of Directors
establishes the CEO's salary by considering the salaries of CEO's of
comparably-sized companies and their performance.
In fiscal 1993, while the Company consummated the $21.8 million
acquisition of certain assets and the business of Medtronic Andover Medical,
Inc. from Medtronic Inc., the Company incurred a net loss of $1.4 million,
primarily as a result of a $5.0 million charge relating to patent infringement
litigation. In fiscal 1994, the Company returned to profitability, recording net
income of $5.4 million, or $0.84 per share. Also in 1994, the Company agreed to
acquire Birtcher Medical Systems, Inc. in a $20.0 million stock-for-stock
exchange, a transaction that was consummated on March 14, 1995.
In the light of the foregoing, pursuant to the terms of Mr. Corasanti's
Employment Agreement, the Board of Directors (Mr. Corasanti abstaining) has
increased Mr. Corasanti's base salary to $250,000 for 1995.
The Board of Directors has adopted similar policies with respect to
compensation of the other executive officers of the Company. Using salary survey
data, the Board of Directors establishes base salaries that are within the range
for persons holding similarly-responsible positions at other companies. In
addition, the Board of Directors considers factors such as relative company
performance, long-term growth and strategic positioning, the individual's past
performance and future potential in establishing the base salaries of executive
officers. The Board of Directors' policy regarding other elements of the
compensation package for executive officers is similar to the CEO's in that the
annual bonus is tied to achievement of performance targets. Cash bonuses
approximating 50% of each executive officer's 1994 base salary were awarded to
executive officers in fiscal year 1994.
Stock options are granted to the Company's executive officers,
including Eugene R. Corasanti, primarily based on the executive's ability to
influence the Company's long-term growth and profitability. The number of
options granted is determined by using the same subjective criteria. All options
are granted at the current market price. Since the value of an option bears a
direct relationship to the Company's stock price it is an effective incentive
for managers to create value for stockholders. The Committee therefore views
stock options as an important component of its long-term, performance-based
compensation philosophy. The Committee granted 75,000 stock options to Eugene R.
Corasanti in fiscal year 1994. No executive officers other than Eugene R.
Corasanti were granted options in fiscal year 1994.
The Board of Directors has not yet adopted a policy with respect to
qualification of executive compensation in excess of $1 million per individual
for deduction under Section 162(m) of the Internal Revenue Code of 1986, as
amended, and the regulations thereunder. The Board of Directors does not
anticipate that the compensation of any executive officer during 1995 will
exceed the limits for deductibility. In determining a policy for future periods,
the Board of Directors would expect to consider all relevant factors, including
the Company's tax position and the materiality of the amounts likely to be
involved.
The Board of Directors
of CONMED Corporation
Eugene R. Corasanti, Chairman
Harry Cone
Robert E. Remmell
Bruce F. Daniels
Joseph J. Corasanti
BOARD OF DIRECTORS INTERLOCKS AND INSIDER PARTICIPATION
The Company's Board of Directors, which is composed of Eugene R.
Corasanti, Harry Cone, Robert E. Remmell, Bruce F. Daniels and Joseph J.
Corasanti, establishes the compensation plans and specific compensation levels
for executive officers and administers the Company's stock option plans through
the Committee. As disclosed above, Eugene R. Corasanti, the Chairman of the
Board of Directors, is the Chief Executive Officer and President of the Company
and also serves as an officer of the Company's subsidiaries. Joseph J.
Corasanti, a director of the Company, is the Vice President of Legal Affairs and
General Counsel of the Company and is the son of Eugene R. Corasanti.
The Company pays all premiums on a $3,175,000 split-dollar life
insurance policy for the benefit of Eugene R. Corasanti. Premiums paid or
accrued by the Company in respect of the fiscal year ended December 30, 1994
were approximately $53,000. Of such premiums, an aggregate of approximately
$10,400 has been reflected as compensation to Mr. Corasanti. The remaining
amounts (approximately $305,700 at December 30, 1994) are backed by the cash
value of the policy or the proceeds on death. An amount equal to such net
premiums (and subsequent premiums) will be repaid to the Company on Mr.
Corasanti's death and the balance of the policy will be paid to Mr. Corasanti's
estate or beneficiaries.
PERFORMANCE GRAPH
The graph below compares the yearly percentage change in the Company's
Common Stock with the cumulative total return of the Center for Research for
Stock Performance ("CRSP") Total Return Index for the NASDAQ Stock Market and
the cumulative total return of the Standard & Poor's Medical Products and
Supplies Industry Group Index. In each case, the cumulative total return assumes
reinvestment of dividends into the same class of equity securities at the
frequency with which dividends are paid on such securities during the applicable
fiscal year.
COMPARISON OF FIVE YEAR TOTAL RETURNS:
CONMED CORPORATION COMMON STOCK,
CRSP TOTAL RETURN INDEX FOR THE NASDAQ STOCK MARKET AND
STANDARD & POOR'S MEDICAL PRODUCTS AND SUPPLIES INDUSTRY GROUP INDEX
[GRAPHIC -- GRAPH PLOTTED TO POINTS INDICATED IN CHART BELOW]
12/89 12/90 12/91 12/92 12/93 12/94
----- ----- ----- ----- ----- -----
CONMED CORPORATION 100 271 800 382 250 701
NASDAQ STOCK MARKET 100 85 136 159 181 177
S&P MEDICAL PRODUCTS
& SUPPLIES INDEX 100 117 192 164 125 149
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
As discussed above under "Board of Directors Interlocks and Insider
Participation," the Company pays all premiums on a $3,175,000 split-dollar life
insurance policy for the benefit of Eugene R. Corasanti. Premiums paid or
accrued by the Company in respect of the fiscal year ended December 30, 1994
were approximately $53,000. Of such premiums, an aggregate of approximately
$10,400 has been reflected as compensation to Mr. Corasanti. The remaining
amounts (approximately $305,700 at December 30, 1994) are backed by the cash
value of the policy or the proceeds on death. An amount equal to such net
premiums (and subsequent premiums) will be repaid to the Company on Mr.
Corasanti's death and the balance of the policy will be paid to Mr. Corasanti's
estate or beneficiaries.
The Company has entered into a directors and officers insurance policy
covering the period from January 31, 1995 through January 31, 1996 at a total
cost of $130,200, which covers directors and officers of the Company and its
subsidiaries.
All transactions with officers, directors, and affiliates of the
Company have been on terms that the Company believes were no less favorable to
the Company than those that could be obtained from an unaffiliated third party
or negotiated in good faith on an arm's-length basis.
PROPOSAL TWO: INDEPENDENT PUBLIC ACCOUNTANTS
The independent accountants for the Company have been Price Waterhouse
since fiscal year 1982. The Audit Committee has recommended to the Board of
Directors that Price Waterhouse be nominated as independent accountants for
fiscal year 1995, and the Board approved the recommendation.
Unless otherwise specified, shares represented by proxies will be voted
for the appointment of Price Waterhouse as independent accountants for fiscal
year 1995. Representatives of Price Waterhouse are expected to be present at the
meeting. Such representatives will have the opportunity to make a statement if
they desire to do so and are expected to be available to respond to appropriate
questions.
The Board of Directors recommends a vote FOR this proposal.
PROPOSAL THREE: ADOPTION OF STOCK OPTION PLAN
FOR NON-EMPLOYEE DIRECTORS
On March 4, 1995, the Board of Directors adopted, subject to
shareholder approval, the Stock Option Plan For Non-Employee Directors of CONMED
Corporation (the "Non-Employee Directors Plan"). The purpose of the Non-Employee
Directors Plan is to attract and retain highly qualified individuals who are not
current or former employees of the Company as members of the Board of Directors
of the Company and to enable them to increase their ownership in the Company's
Common Stock.
Summary Description of the Non-Employee Directors Plan
The major provisions of the Non-Employee Directors Plan are summarized
below. The following summary is qualified in its entirety by reference to the
complete text of the Non-Employee Directors Plan, which is attached as Exhibit A
to this Proxy Statement.
Eligibility. All members of the Company's Board of Directors who are
not current or former employees of the Company or any of its subsidiaries
("Non-Employee Directors") are eligible to participate in the Non-Employee
Directors Plan. If the Company's Stock Option Plan for Non-Employee Directors is
approved at the 1995 Annual Meeting, each non-employee director (Messrs. Cone,
Daniel and Remmell in 1995) who is elected, reelected or continuing as a
director will receive 1,000 options with an option price equal to the fair
market value of the Company's Common Stock on the business day following each
annual meeting of the shareholders, commencing with the annual meeting in 1995.
Common Stock Subject to the Non-Employee Directors Plan. A total of
50,000 shares of Common Stock (subject to adjustment for stock splits and other
changes in the Company's capital structure) are reserved against the exercise of
options to be granted under the Non-Employee Directors Plan. Shares issuable
under the Non-Employee Directors Plan may be authorized but unissued shares or
treasury shares. Shares reserved under an option which for any reason expires or
is terminated, in whole or in part, shall again be available for the purposes of
the Non-Employee Directors Plan.
Options to be Granted. Under the Non-Employee Directors Plan, each year
on the first business day following the Company's Annual Meeting, each
individual elected, reelected or continuing as a Non-Employee Director shall
automatically receive stock options covering 1,000 shares of the Company's
Common Stock.
Administration and Amendment. The Non-Employee Directors Plan shall be
administered by the Board of Directors. The Non-Employee Directors Plan may be
terminated or suspended by the Board of Directors as they deem advisable. The
Board of Directors may amend the Non-Employee Directors Plan from time to time
in any respect the Board of Directors may deem to be in the best interests of
the Company; provided, however, that (a) no amendment shall be effective without
approval of the shareholders of the Company, if shareholder approval of the
amendment is then required pursuant to Rule 16b-3 under the Securities Exchange
Act of 1934 (the "Exchange Act"), or the applicable rules of any securities
exchange or consolidated reporting system and (b) to the extent prohibited by
Rule 16b-3(c)(2)(ii)(B) under the Exchange Act, the Non-Employee Directors Plan
may not be amended more than once every six months unless necessary to comply
with the Internal Revenue Code of 1986, as amended. A stock option may not be
granted under the Non-Employee Directors Plan after May 23, 2003, but stock
options granted prior to that date shall continue to become exercisable and may
be exercised according to their terms.
Provisions of Options. Each option shall have the following provisions:
(a) The option price shall be the fair market value of the Common Stock
on the date of its grant.
(b) Each option shall expire ten years from the date of grant. Subject
to early termination or acceleration provisions (which are summarized below), an
option shall become exercisable one year from the date of its grant until the
expiration of the term of the option.
(c) An option may not be transferred by an optionee otherwise than by
will or by the laws of descent and distribution, and may be exercised during his
lifetime only by the optionee.
(d) The exercise price of any option shall be paid in cash.
(e) Upon termination of service as a Non-Employee Director (other than
for reasons of retirement, disability or death), all stock options of such
Non-Employee Director shall terminate immediately. If a non-Employee Director's
service is terminated by reason of disability or retirement with the consent of
the Board of Directors (other than the optionee), such optionee's stock options
shall be exercisable at any time prior to the expiration date of the stock
option or within 90 days after the date of such termination, whichever is the
shorter period. If a Non-Employee Director's service is terminated as a result
of such Non-Employee Director's death, such Non-Employee Director's stock
options shall be exercisable by the person or persons to whom those rights pass
by will or by the laws of descent and distribution at any time prior to the
expiration date of the stock option or within 90 days after the date of such
death, whichever is the shorter period.
Compliance with SEC Regulations; Governmental Compliance. It is the
Company's intent that the Non-Employee Directors Plan comply in all respects
with Rule 16b-3 under the Exchange Act, and any regulations promulgated
thereunder. All grants of stock options under the Non-Employee Directors Plan
shall be executed in accordance with the requirements of Rule 16b-3 under the
Exchange Act. Each grant under the Non-Employee Directors Plan shall be subject
to the requirement that if at any time the Board of Directors shall determine
that the listing, registration or qualification of any shares issuable or
deliverable thereunder upon any securities exchange or under any federal or
state law, or the consent or approval of any governmental regulatory body, is
necessary or desirable as a condition thereof, or in connection therewith, no
such grant may be exercised or shares issued or delivered unless such listing,
registration, qualification, consent or approval shall have been effected or
obtained free of any conditions not acceptable to the Board of Directors.
Federal Tax Treatment of Options. An optionee will not realize taxable
income, and the Company will not be entitled to a deduction, at the time that a
nonqualified stock option is granted under the Non-Employee Directors Plan. Upon
exercising a nonqualified stock option, an optionee will realize ordinary
income, and the Company will be entitled to a corresponding deduction, in an
amount equal to the excess of the fair market value on the exercise date of the
shares subject to the option over the exercise price of the option. The optionee
will have a basis, for purposes of computing capital gain or loss on a future
sale or exchange, in the shares received as a result of the exercise equal to
the fair market value of those shares on the exercise date.
Adjustment to Outstanding Warrant. Under the terms of a warrant dated
as of August 31, 1989 (the "Warrant"), Zimmer, Inc. has the right to purchase
approximately 461,909 shares of Common Stock at approximately $6.49 per share in
cash on or after September 1, 1992. Under the terms of the Warrant, the issuance
of options under the Non-Employee Directors Plan would result in an adjustment
to the number of shares Zimmer, Inc. is entitled to purchase under the Warrant
and the purchase price therefor if the exercise price at which options are
granted under the Non-Employee Directors Plan were lower than (i) the warrant
exercise price at the time of such issuance, or (ii) the then market price of
the Common Stock, which, for purposes of the Warrant, is calculated by averaging
over 30 business days the price of the Common Stock as reported in the Nasdaq
National Market.
Benefits to be Received by Non-Employee Directors
Under the Non-Employee Directors Plan
The following chart indicates the amounts that would have been
allocated to the Non-Employee Director group for the last fiscal year had the
Non-Employee Directors Plan been in effect during the Company's last fiscal
year:
Dollar Value (1) Number of Units
---------------- ---------------
Non-Executive Director Group $22,140 3,000
(1) Based on $19.88 per share fair market value on December 30, 1994 less $12.50
per share fair market value on May 18, 1994 (the business day following the
1994 Annual Meeting of Shareholders)
The affirmative vote of the holders of a majority of the total
outstanding shares of Common Stock is necessary for adoption of the Non-Employee
Directors Plan.
The Board of Directors recommends a vote FOR approval of the proposed
amendment.
OTHER BUSINESS
Management knows of no other business which will be presented for
consideration at the Annual Meeting, but should any other matters be brought
before the meeting, it is intended that the persons named in the accompanying
proxy will vote such proxy at their discretion.
SHAREHOLDER PROPOSALS FOR 1996 ANNUAL MEETING
Any shareholder desiring to present a proposal to the shareholders at
the 1996 Annual Meeting, which currently is expected to be scheduled on or about
May 21, 1996, and who desires that such proposal be included in the Company's
proxy statement and proxy card relating to that meeting, must transmit such to
the Company so that it is received by the Company at its principal executive
offices on or before January 22, 1996. All such proposals should be in
compliance with applicable SEC regulations. In addition, shareholders wishing to
propose matters for consideration at the 1995 Annual Meeting or to propose
nominees for election as directors at the 1995 Annual Meeting must follow
specified advance notice procedures contained in the Company's By-laws, a copy
of which is available on request to the Secretary of the Company, c/o CONMED
Corporation, 310 Broad Street, Utica, New York 13501.
By Order of the Board of Directors,
Thomas M. Acey
Secretary
April 19, 1995
STOCK OPTION PLAN
FOR NON-EMPLOYEE DIRECTORS
OF CONMED CORPORATION
The Stock Option Plan for Non-Employee Directors of CONMED
Corporation (this "Plan") is established to attract and retain highly qualified
individuals who are not current or former employees of CONMED Corporation (the
"Company") as members of the Board of Directors of the Company and to enable
them to increase their ownership in the common stock, par value $0.01 per share,
of the Company (the "Company's Common Stock"). This Plan will be beneficial to
the Company and its stockholders because it will allow these directors to have a
greater personal financial stake in the Company through the ownership of the
Company's Common Stock, in addition to underscoring their common interest with
stockholders in increasing the long-term value of the Company's Common Stock.
1. ELIGIBILITY
All members of the Company's Board of Directors who are not
current or former employees of the Company or any of its subsidiaries
("Non-Employee Directors") are eligible to participate in this Plan.
2. SHARES AVAILABLE
(a) Number of Shares Available. Stock options may be granted
under this Plan to purchase up to a maximum of 50,000 shares of the Company's
Common Stock, subject to adjustment, as hereinafter provided. Shares issuable
under this Plan may be authorized but unissued shares or treasury shares. If any
stock option granted under this Plan expires or otherwise terminates without
having been exercised, the shares subject to the unexercised portion of such
stock option shall continue to be available for the granting of stock options
under this Plan.
(b) Recapitalization Adjustment. In the event of a
reorganization, recapitalization, stock split, stock dividend, combination of
shares, merger, consolidation, rights offering, or any other change in the
corporate structure or shares of the Company, adjustments in the number and kind
of shares authorized by this Plan, in the number and kind of shares covered by,
and in the option price of outstanding stock options under, this Plan shall be
made if, and in the same manner as, such adjustments are made to stock options
issued under the Company's then current stock option plans.
3. ANNUAL GRANT OF NONQUALIFIED STOCK OPTIONS
Each year on the first business day following the Company's
Annual Meeting of Stockholders, each individual elected, reelected or continuing
as a Non-Employee Director shall automatically receive stock options covering
1,000 shares of the Company's Common Stock. If the Company's Common Stock is not
listed for quotation on the Nasdaq National Market on any such date a grant
would otherwise be awarded, then such grant shall be made the next day
thereafter that the Company's Common Stock is so listed on Nasdaq National
Market or any national securities exchange or inter-dealer automated quotation
system.
4. OPTION PRICE
The price of each stock option granted under this Plan shall
be the Fair Market Value (as defined below) on the date of grant of such option.
For purposes of this Plan, "Fair Market Value" shall mean, as of any date, (i)
if the Company's Common Stock is listed or admitted to unlisted trading
privileges on any national securities exchange or is not so listed or admitted
but transactions in the Company's Common Stock are reported on the Nasdaq
National Market, the mean between the reported high and low sale prices of the
Company's Common Stock on such exchange or by the Nasdaq National Market as of
such date (or, if no such shares were traded on such date, as of the next
preceding day on which there was such a trade); or (ii) if the Company's Common
Stock is not so listed or admitted to unlisted trading privileges or reported on
the Nasdaq National Market, and bid and asked prices therefor in the
over-the-counter market are reported by the National Association of Securities
Dealers, Inc. or the National Quotation Bureau, Inc. (or any comparable
reporting service), the mean of the closing bid and ask prices of the Company's
Common Stock as of such date, as so reported; or (iii) if the Company's Common
Stock is not so listed or reported, such value as the Board of Directors of the
Company determines in good faith in the exercise of its reasonable discretion.
5. OPTION PERIOD
A stock option granted under this Plan shall become
exercisable one year after date of grant and shall expire ten years after date
of grant (the "Option Period").
6. PAYMENT
The stock option price shall be paid in cash in U.S. dollars
at the time the stock option is exercised.
7. TERMINATION OF SERVICE
Upon termination of service as a Non-Employee Director (other
than for reasons of retirement, disability or death), all stock options of such
optionee shall terminate immediately. If an optionee's service is terminated by
reason of disability or retirement with the consent of the Board of Directors
(other than the optionee), such optionee's stock options shall be exercisable at
any time prior to the expiration date of the stock option or within 90 days
after the date of such termination, whichever is the shorter period. If an
optionee's service is terminated as a result of such optionee's death, such
optionee's stock options shall be exercisable by the person or persons to whom
those rights pass by will or by the laws of descent and distribution at any time
prior to the expiration date of the stock option or within 90 days after the
date of such death, whichever is the shorter period.
8. ADMINISTRATION AND AMENDMENT OF THIS PLAN
This Plan shall be administered by the Board of Directors of
CONMED Corporation. This Plan may be terminated or suspended by the Board of
Directors as they deem advisable. The Board of Directors may amend this Plan
from time to time in any respect the Board of Directors may deem to be in the
best interests of the Company; provided, however, that (a) no such amendment
shall be effective without approval of the shareholders of the Company, if
shareholder approval of the amendment is then required pursuant to Rule 16b-3
under the Securities Exchange Act of 1934 (the "Exchange Act"), or the
applicable rules of any securities exchange or consolidated reporting system,
and (b) to the extent prohibited by Rule 16b-3(c)(2)(ii)(B) under the Exchange
Act, this Plan may not be amended more than once every six months unless
necessary to comply with the Internal Revenue Code of 1986, as amended. A stock
option may not be granted under this Plan after May 23, 2005, but stock options
granted prior to that date shall continue to become exercisable and may be
exercised according to their terms.
9. NONTRANSFERABILITY
No stock option granted under this Plan is transferable other
than by will or the laws of descent and distribution. During the optionee's
lifetime, a stock option may only be exercised by the optionee or the optionee's
guardian or legal representative.
10. COMPLIANCE WITH SEC REGULATIONS
It is the Company's intent that this Plan comply in all
respects with Rule 16b-3 under the Exchange Act, and any regulations promulgated
thereunder. If any provision of this Plan is later found not to be in compliance
with Rule 16b-3 under the Exchange Act, the provision shall be deemed null and
void. All grants of stock options under this Plan shall be executed in
accordance with the requirements of Rule 16b-3 under the Exchange Act.
11. GOVERNMENTAL COMPLIANCE
Each grant under this Plan shall be subject to the requirement
that if at any time the Board of Directors shall determine that the listing,
registration or qualification of any shares issuable or deliverable thereunder
upon any securities exchange or under any federal or state law, or the consent
or approval of any governmental regulatory body, is necessary or desirable as a
condition thereof, or in connection therewith, no such grant may be exercised or
shares issued or delivered unless such listing, registration, qualification,
consent or approval shall have been effected or obtained free of any conditions
not acceptable to the Board of Directors.
12. MISCELLANEOUS
Except as provided in this Plan, no Non-Employee Director
shall have any claim or right to be granted a stock option under this Plan.
Neither this Plan nor any action thereunder shall be construed as giving any
director any right to be retained in the service of the Company.
13. GOVERNING LAW
This Plan and all rights and obligations under this Plan shall
be construed in accordance with and governed by the laws of the State of New
York.
14. EFFECTIVE DATE
This Plan shall be effective May 23, 1995 or such later date
as stockholder approval is obtained.
CONMED CORPORATION
310 Broad Street--Utica, New York 13501
Annual Meeting of Shareholders--May 23, 1995
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS
The undersigned hereby appoints Eugene R. Corasanti and Robert E.
Remmell, and either of them, proxies of the undersigned, with full power of
substitution, to vote all the shares of Common Stock of CONMED Corporation (the
"Company") held of record by the undersigned on April 4, 1995, at the Annual
Meeting of Shareholders to be held May 23, 1995, and at any adjournment thereof.
(1) Election of Directors
[ ] FOR all nominees listed below [ ] WITHHOLD AUTHORITY to vote
(except as indicated otherwise for all nominees listed below
below)
NOMINEES: Harry Cone, Robert E. Remmell, Eugene R. Corasanti,
Bruce F. Daniels and Joseph J. Corasanti.
INSTRUCTIONS: To withhold authority to vote for any individual nominee,
write such nominee's name on the space provided below.
------------------------------------------------------------
(2) Appointment of Price Waterhouse as Independent Accountants of the Company
for the fiscal year 1995.
[ ] FOR [ ] AGAINST [ ] ABSTAIN
(3) Adoption of the Company's Stock Option Plan for Non-Employee Directors.
[ ] FOR [ ] AGAINST [ ] ABSTAIN
(4) In their discretion the proxies are authorized to vote upon such other
matters as may come before the meeting or any adjournment thereof.
All as more particularly described in the Company's Proxy Statement, dated
April 19, 1995, relating to such meeting, receipt of which is hereby
acknowledged.
THIS PROXY WHEN PROPERLY EXECUTED WILL BE VOTED AS SPECIFIED BY THE
UNDERSIGNED SHAREHOLDER. IF NO CHOICE IS SPECIFIED BY THE SHAREHOLDER, THIS
PROXY WILL BE VOTED "FOR" ALL PORTIONS OF ITEMS (1), (2) AND (3), AND IN THE
PROXIES' DISCRETION ON ANY OTHER MATTERS COMING BEFORE THE MEETING.
The undersigned hereby revokes any proxy or proxies heretofore given to
vote upon or act with respect to such stock and hereby ratifies and confirms all
that said proxies, their substitutes or any of them may lawfully do by virtue
hereof.
- ----------------------------------------
- ----------------------------------------
Dated: ___________________________, 1995
Please date this Proxy Card and sign
your name exactly as it appears hereon.
Where there is more than one owner, each
should sign. When signing as an
attorney, administrator, executor,
guardian, or trustee, please add your
title as such. If executed by a
corporation, this Proxy Card should be
signed by a duly authorized officer. If
executed by a partnership, please sign
in partnership name by authorized
persons.
Please promptly mark, date, sign and mail this Proxy Card in the enclosed
envelope. No postage is required.
